|
 |
|
|||||||
|
|||||||||
© 2002 by the American Diabetes Association, Inc.
Reviews/Commentaries/Position Statements |
Continuous Subcutaneous Insulin Infusion at 25 Years
Evidence base for the expanding use of insulin pump therapy in type 1 diabetes
From the Department of Chemical Pathology and Metabolic Unit, Guy’s King’s and St Thomas’ Hospitals School of Medicine, Guy’s Hospital, London, U.K.
Continuous subcutaneous insulin infusion (CSII) is used in selected type 1 diabetic subjects to achieve strict blood glucose control. A quarter of a century after its introduction, world-wide use of CSII is increasing. We review the evidence base that justifies this increase, including effectiveness compared with modern intensified insulin injection regimens and concern about possible complications. Review of controlled trials shows that, in most patients, mean blood glucose concentrations and glycated hemoglobin percentages are either slightly lower or similar on CSII versus multiple insulin injections. However, hypoglycemia is markedly less frequent than during intensive injection therapy. Ketoacidosis occurs at the same rate. Nocturnal glycemic control is improved with insulin pumps, and automatic basal rate changes help to minimize a prebreakfast blood glucose increase (the "dawn phenomenon") often seen with injection therapy. Patients with "brittle" diabetes characterized by recurrent ketoacidosis are often not improved by CSII, although there may be exceptions. We argue that explicit clinical indications for CSII are helpful; we suggest the principal indications for health service or health insurance–funded CSII should include frequent, unpredictable hypoglycemia or a marked dawn phenomenon, which persist after attempts to improve control with intensive insulin injection regimens. In any circumstances, candidates for CSII must be motivated, willing and able to undertake pump therapy, and adequately psychologically stable. Some diabetic patients with well-defined clinical problems are likely to benefit substantially from CSII and should not be denied a trial of the treatment. Their number is relatively small, as would therefore be the demand on funds set aside for this purpose.
Abbreviations: CSII, continuous subcutaneous insulininfusion • DCCT, Diabetes Control and Complications Trial
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  S. W. Ponder, J. S. Skyler, D. F. Kruger, D. Matheson, and B. W. Brown Unexplained Hyperglycemia in Continuous Subcutaneous Insulin Infusion: Evaluation and Treatment The Diabetes Educator, March 1, 2008; 34(2): 327 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Skyler, S. Ponder, D. F. Kruger, D. Matheson, and C. G. Parkin Is There a Place for Insulin Pump Therapy in Your Practice? Clin. Diabetes, April 1, 2007; 25(2): 50 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.-M. Holterhus, R. Odendahl, S. Oesingmann, R. Lepler, V. Wagner, O. Hiort, R. Holl, and the German/Austrian DPV Initiative and the German Classification of Distinct Baseline Insulin Infusion Patterns in Children and Adolescents With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy Diabetes Care, March 1, 2007; 30(3): 568 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Valenzuela, A. M. Patino, J. McCullough, C. Ring, J. Sanchez, M. Eidson, R. Nemery, and A. M. Delamater Insulin Pump Therapy and Health-Related Quality of Life in Children and Adolescents with Type 1 Diabetes J. Pediatr. Psychol., July 1, 2006; 31(6): 650 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Pickup Point: Are Insulin Pumps Underutilized in Type 1 Diabetes? Yes. Diabetes Care, June 1, 2006; 29(6): 1449 - 1452. [Full Text] [PDF]
|
|
|
|
|
|
D. S. Schade and V. Valentine Counterpoint: Are Insulin Pumps Underutilized in Type 1 Diabetes? No. Diabetes Care, June 1, 2006; 29(6): 1453 - 1455. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Berhe, D. Postellon, B. Wilson, and R. Stone Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study. Pediatrics, June 1, 2006; 117(6): 2132 - 2137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lepore, A. R. Dodesini, I. Nosari, and R. Trevisan Age and A1C Are Important Clinical Predictors of Continuous Subcutaneous Insulin Infusion Efficacy in Type 1 Diabetic Patients Diabetes Care, July 1, 2005; 28(7): 1834 - 1835. [Full Text] [PDF]
|
|
|
|
|
|
D. M. Wilson, B. A. Buckingham, E. L. Kunselman, M. M. Sullivan, H. U. Paguntalan, and S. E. Gitelman A Two-Center Randomized Controlled Feasibility Trial of Insulin Pump Therapy in Young Children With Diabetes Diabetes Care, January 1, 2005; 28(1): 15 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Peyrot and R. R. Rubin Validity and Reliability of an Instrument for Assessing Health-Related Quality of Life and Treatment Preferences: The Insulin Delivery System Rating Questionnaire Diabetes Care, January 1, 2005; 28(1): 53 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Retnakaran, J. Hochman, J. H. DeVries, H. Hanaire-Broutin, R. J. Heine, V. Melki, and B. Zinman Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections: The impact of baseline A1c Diabetes Care, November 1, 2004; 27(11): 2590 - 2596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Bulsara, C. D. J. Holman, E. A. Davis, and T. W. Jones The Impact of a Decade of Changing Treatment on Rates of Severe Hypoglycemia in a Population-Based Cohort of Children With Type 1 Diabetes Diabetes Care, October 1, 2004; 27(10): 2293 - 2298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.A. Saunders, M. Wallymahmed, and I.A. MacFarlane Glycaemic control in a type 1 diabetes clinic for younger adults QJM, September 1, 2004; 97(9): 575 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. T. Mucha, S. Merkel, W. Thomas, and J. P. Bantle Fasting and Insulin Glargine in Individuals With Type 1 Diabetes Diabetes Care, May 1, 2004; 27(5): 1209 - 1210. [Full Text] [PDF]
|
|
|
|
|
|
Continuous Subcutaneous Insulin Infusion Diabetes Care, January 1, 2004; 27(90001): s110 - 110. [Full Text] [PDF]
|
|
|
|
 |
|
 T Torrance, V Franklin, and S Greene Insulin pumps Arch. Dis. Child., November 1, 2003; 88(11): 949 - 953. [Full Text] [PDF]
|
|
|
|
|
|
L. P. Plotnick, L. M. Clark, F. L. Brancati, and T. Erlinger Safety and Effectiveness of Insulin Pump Therapy in Children and Adolescents With Type 1 Diabetes Diabetes Care, April 1, 2003; 26(4): 1142 - 1146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Continuous Subcutaneous Insulin Infusion Diabetes Care, January 1, 2003; 26(90001): s125 - 125. [Full Text] [PDF]
|
|
|
|
|
|
S. J. Kanakis, C. Watts, and S. B. Leichter The Business of Insulin Pumps in Diabetes Care: Clinical and Economic Considerations Clin. Diabetes, October 1, 2002; 20(4): 214 - 216. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |